Effects of angiotensin-converting enzyme and neutral endopeptidase inhibitors: Influence of bradykinin

European Journal of Pharmacology

Volumn 296, Issue 3, 1996, Pages 267-276

  Pham, Isabelle ^a   Gonzalez, Walter ^a   Doucet, Jean ^a   Fournié Zaluski, Marie Claude ^b   Roques, Bernard P ^b   Michel, Jean Baptiste ^a  

^a INSERM   (France)

^b Laboratoire de Pharmacochimie   (France)

Author keywords

Angiotensin converting enzyme inhibitor; Bradykinin; DOCA salt rat; Neutral endopeptidase inhibitor

Indexed keywords

BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; CYCLIC GMP; DEOXYCORTICOSTERONE ACETATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT; ENKEPHALINASE INHIBITOR; ICATIBANT; PROSTAGLANDIN; PROTEINASE INHIBITOR; RETROTHIORPHAN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG POTENTIATION; HYPERTENSION; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; URINARY EXCRETION;

EID: 0030026249     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00706-7     Document Type: Article

References (48)

1. Alhenc-Gélas, F., J. Marchetti, J. Allegrini, P. Corvol and J. Menard, 1981, Measurement of kallikrein activity by kinin radioimmunoassay. Species differences in kinin production, Biochim. Biophys. Acta 677, 477.
2. Bao, G., P. Gohlke, F. Qadri and T. Unger, 1992, Chronic kinin receptor blockade attenuates the antihypertensive effects of ramipril, Hypertension 20, 74.
3. Bralet, J., C. Mossiat, C. Gros and J. Schwartz, 1991, Thiorphan-induced natriuresis in volume-expanded rats: roles of endogenous atrial natriuretic factor and kinins, J. Pharmacol. Exp. Ther. 258, 807.
4. Cachofeiro, V. and A. Nasjletti, 1991, Increased vascular responsiveness to bradykinin in kidneys spontaneously hypertensive rats. Effects of Af-nitro-L-arginine, Hypertension 18, 683.
5. Cachofeiro, V., T. Sakakibara and A. Nasjletti, 1992, Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension, Hypertension 19, 138.
6. Carbonell, L.F., O.A. Carretero, J.M. Stewart and A.G. Scicli, 1988, Effect of a kinin antagonist on the acute antihypertensive activity of enalaprilat in severe hypertension, Hypertension 11, 239.
7. Carone, F.A., T.N. Pullman, S. Oparil and S. Nakamura, 1976, Micropuncture evidence of rapid hydrolysis of bradykinin by rat proximal tubule, Am. J. Physiol. 230, 1420.
8. D'Orléans-Juste, P., G. de Nucci and J. Vane, 1989, Kinins act on B1 or B2 receptors to release conjointly endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells, Br. J. Pharmacol. 96, 920.
9. Fenoy, F.J., G. Scicli, O. Carretero and R.J. Roman, 1991, Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril, Hypertension 17, 1038.
10. Fournié-Zaluski, M.-C., W. Gonzales, S. Turcaud, I. Pham, B. Roques and J.-B. Michel, 1994, Dual inhibition of angiotensin converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril I; a new therapeutic approach in hypertension, Proc. Natl. Acad. Sci. USA 91, 4072.
11. Gafford, J.T., R.A. Skidgel, E.G. Erdös and L.B. Hersh, 1983, Human kidney "enkephalinase", a neutral metalloendopeptidase that cleaves active peptides, Biochemistry 22, 3265.
12. Garcia-Perez, A. and W. Smith, 1984, Apical-basolateral membrane asymetry in canine cortical collecting tubule cells, J. Clin. Invest. 74, 63.
13. Gonzalez Vera, W., M.-C. Fournié-Zaluski, I. Pham, I. Laboulandine, B. Roques and J.-B. Michel, 1995, Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats, J. Pharmacol. Exp. Ther. 272, 343.
14. Graf, K., C. Bossaler, M. Gräfe, W. Auch-Schwelk, C.R. Baumgarten, J. Niehus and E. Fleck, 1991, Neutral endopeptidase is involved in endothelial degradation of kinins, Circulation 84 (Suppl. II), II-52.
15. Gräfe, M., C. Bossaler, K. Graf, W. Auch-Schwelk, C.R. Baumgarten, A. Hidebrandt and E. Fleck, 1993, Effect of angiotensin-converting enzyme inhibition on bradykinin metabolism by vascular endothelial cells, Am. J. Physiol. 264, H1493.
16. Hirata, Y., H. Matsuoka, H. Hayakawa, T. Sugimoto, E. Suzuki, K. Kangawa and H. Matsuo, 1990, Role of endogenous atrial natriuretic peptide in regulating sodium excretion in spontaneously hypertensive rats, Hypertension 17, 1025.
17. Hirata, Y., H. Matsuoka, E. Suzuki, H. Hayakawa, T. Sugimoto, Y. Matsuda, Y. Morishita, K. Kangawa, N. Minamino, H. Matsuo and T. Sugimoto, 1993, Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor, Circulation 87, 554.
18. Hirata, Y., Y. Suzuki, E. Suzuky, H. Hayakawa, K. Kimura, A. Goto, Y. Matsuda and M. Omata, 1994, Mechanisms underlying the augmented responses of DOCA-salt hypertensive rats to neutral endopeptidase inhibition, J. Hypertens. 12 (Suppl. 3), S102.
19. 22Na in the rat nephron, J. Pharmacol. Exp. Ther. 214, 119.
20. Llorens-Cortes, C., H. Huang, P. Vicart, J.-M. Gasc, D. Paulin and P. Corvol, 1992, Identification and characterization of neutral endopeptidase in endothelial cells from venous or arterial origins, J. Biol. Chem. 267, 14012.
21. Lortie, M., D. Regoli, N.-E. Rhaleb and G. Plante, 1992, The role of Bl-and B2-kinin receptors in the renal tubular and hemodynamic response to bradykinin, Am. J. Physiol. 262, R72.
22. Madeddu, P., V. Anania, P.P. Parpaglia, M.P. Dementis, V.M. Varoni, G. Pisanu, C. Troffa, G. Tonolo and N. Glorioso, 1992, Effects of Hoe 140, a bradykinin B2-receptor antagonist, on renal function in conscious normotensive rats, Br. J. Pharmacol. 106, 380.
23. Margolius, H.S., R. Geller, J.J. Pisano and A. Sjoerdsma, 1971, Altered urinary kallikrein excretion in human hypertension, Lancet 2, 1063.
24. Margolius, H.S., R. Geller, W. De Jong, J.J. Pisano and A. Sjoerdsma, 1972, Altered urinary kallikrein excretion in rats with hypertension, Circ. Res. 30, 358.
25. Mattson, D. and A. Cowley Jr., 1993, Kinin actions on renal papillary blood flow and sodium excretion, Hypertension 21, 961.
26. Miyamoto, M., H. Koike, K. Ito and M. Yamazaki, 1981, Effects of captopril on urinary excretion of prostaglandins and electrolytes in spontaneously hypertensive rats, Eur. J. Pharmacol. 76, 187.
27. Münzel, T., S. Kurz, J. Holtz, R. Busse, H. Steinhauer, H. Just and H. Drexler, 1992, Neurohormonal inhibition and hemodynamic unloading during prolonged inhibition of ANF degradation in patients with severe chronic heart failure, Circulation 86, 1089.
28. Pham, I., A.-I. El Amrani, M.-C. Fournié-Zaluski, P. Corvol, B. Roques and J.-B. Michel, 1992, Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in normotensive and in DOCA-salt hypertensive rats, J. Cardiovasc. Pharmacol. 20, 847.
29. Pham, I., W. Gonzalez, A.-I. El Amrani, M.-C. Fournié-Zaluski, M. Philippe, I. Laboulandine, B. Roques and J.-B. Michel, 1993, Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension, J. Pharmacol. Exp. Ther. 265, 1339.
30. Roques, B., E. Lucas-Soroca, P. Chaillet, J. Costentin and M.-C. Fournié-Zaluski, 1983, Complete differenciation between enkephalinase and angiotensin converting-enzyme inhibition by retro-thiorphan, Proc. Natl. Acad. Sci. USA 80, 3178.
31. Roques, B., F. Noble, V. Dauge, M.-C. Fournié-Zaluski and A. Beaumont, 1993, Neutral endopeptidase 24.11. Structure, inhibition, experimental and clinical pharmacology, Pharmacol. Rev. 45, 87.
32. + transport in isolated rat CCD: effects of bradykinin, ANP, clonidine, and hydrochlorothiazide, Am. J. Physiol. 260, F86.
33. Schulz, W.W., H.K. Hagler, L.M. Buja and E.G. Erdös, 1988, Ultrastructural localization of angiotensin I-converting enzyme (EC 3.4.15.1) and the neutral metalloendopeptidase (EC 3.4.24.11) in the proximal tubule of the human kidney, Lab. Invest. 59, 789.
34. Scicli, A.G. and O.A. Carretero, 1986, Renal kallikrein-kinin system, Kidney Int. 29, 120.
35. Seymour, A., J. Sheldon, P. Smith, M. Asaad and W. Rogers, 1994, Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs, J. Pharmacol. Exp. Ther. 269, 263.
36. Siragy, H., 1993, Evidence that intrarenal bradykinin plays a role in regulation of renal function, Am. J. Physiol. 265, E648.
37. Smits, G.J., D.E. Mc Graw and A.J. Trapani, 1990, Interaction of ANP and bradykinin during endopeptidase 24.11. inhibition: renal effects, Am. J. Physiol. 258, F1417.
38. Soleilhac, J.-M., E. Lucas, A. Beaumont, S. Turcaud, J.-B. Michel, P. Crine, M.-C. Fournié-Zaluski and B.P. Roques, 1992, A 94 kdalton protein, identified as neutral endopeptidase-24.11, can inactivate atrial natriuretic peptide in vascular tissue, Mol. Pharmacol. 41, 609.
39. Stoos, B.A., O.A. Carretero and J.L. Garvin, 1992, ANF and bradykinin synergistically inhibits transport in M-1 cortical collecting duct cell line, Am. J. Physiol. 263, F1.
40. Sybertz, E.J., P.J.S. Chiu, S. Vemupalalli, R. Watkins and M. Haslanger, 1990, Atrial natriuretic factor-potentiating and antihypertensive inhibitor, Hypertension 15, 152.
41. Tomita, K. and J.J. Pisano, 1984, Binding of (3H)bradykinin isolated nephron segments of the rabbit, Am. J. Physiol. 246, F732.
42. Trippodo, N., B. Panchal and M. Fox, 1995, Repression of angiotensin II and potentiation of bradykinin contribute to the synergistic effects of dual metalloprotease inhibition in heart failure, J. Pharmacol. Exp. Ther. 272, 619.
43. Ura, N., O.A. Carretero and E.G. Erdös, 1987, Role of renal endopeptidase 24. 11 in kinins metabolism in vitro and in vivo, Kidney Int. 32, 507.
44. Wiemer, G. and K. Wirth, 1992, Production of cyclic GMP via activation of B1 and B2 kinin receptors in cultured bovine aortic endothelial cells, J. Pharmacol. Exp. Therap. 262, 729.
45. Willis, L.R., J.H. Ludens, J.B. Hook and H.E. Williamson, 1969, Mechanism of natriuretic action of bradykinin, Am. J. Physiol. 217, 1.
46. Wirth, K., F. Hock, U. Albus, W. Linz, H. Alpermann, H. Anagnostopoulos, S. Henke, G. Breipohl, W. König, J. Knolle and B. Schölkens, 1991, Hoe 140 a new potent and long acting bradykinin antagonist: in vivo studies, Br. J. Pharmacol. 102, 774.
47. Wong, K.R., M.H. Xie, L.B. Shi, F.Y. Liu, C.L. Huang, D.G. Gardner and M.G. Cogan, 1988, Urinary cGMP as a biological marker of the renal activity of atrial natriuretic factor, Am. J. Physiol. 255, F1220.
48. + uptake by rabbit inner medullary collecting duct cells, Am. J. Physiol. 258, F1584.